Literature DB >> 6951831

Induction of estrogen sulfotransferase in the human endometrium by progesterone in organ culture.

C L Clarke, J B Adams, B G Wren.   

Abstract

It has been established that progesterone will induce 17 beta-estradiol (E2) dehydrogenase in the human endometrium. Whether it plays a similar role in the induction of estrogen sulfotransferase is not known, although this is likely, since estrone sulfate is the main metabolite of E2 when incubated with secretory, but not proliferative, human endometrium. We have now examined the influence of progesterone on both enzymes in endometrial tissue in organ culture. Estrogen sulfotransferase activity was not detectable in the cytosol of proliferative tissue when cultured in the absence of hormone, but was induced by culture in the presence of progesterone to a value (mean +/- SEM) of 19.7 +/- 5.3 pmol E2-3-sulfate h-1 mg cytosol protein-1. A significant (P less than 0.05) induction of E2 dehydrogenase activity was also observed in the same tissues [from 3.7 +/- 1.9 to 10.4 +/- 2.7 (mean +/- SEM) nmol estrone h-1 mg microsomal protein-1]. Corresponding values for secretory endometrium, when cultured under identical conditions in the absence of progesterone, were 20.3 +/- 11.6 pmole h-1 mg-1 and 31.1 +/- 25.1 nmol h-1 mg-1 for estrogen sulfotransferase and E2 dehydrogenase, respectively. Values not significantly different from these were obtained when progesterone was present in the cultures. These data indicate that progesterone secretion during the luteal phase is responsible for the induction of both E2 dehydrogenase and sulfotransferase activities in the endometrium. It is likely that these enzymes are closely coupled, resulting in the rapid metabolism of E2 by formation and excretion of estrone sulfate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6951831     DOI: 10.1210/jcem-55-1-70

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Enzymatic regulation of estradiol-17 beta concentrations in human breast cancer cells.

Authors:  J B Adams
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

2.  Purification and some characteristics of an oestrogen sulphotransferase from guinea pig adrenal gland and its non-identity with adrenal pregnenolone sulphotransferase.

Authors:  R Hobkirk; M A Glasier; L Y Brown
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

3.  Development and characteristics of an oestrogen sulphotransferase in placenta and uterus of the pregnant mouse. Comparison between mouse and rat.

Authors:  R Hobkirk; C A Cardy; F Saidi; T G Kennedy; L R Girard
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

4.  Estrone sulfatase activity in normal and abnormal endometrium.

Authors:  G L Adessi; O Prost; G Agnani; A Petitjean; J Burnod
Journal:  Arch Gynecol       Date:  1984

5.  Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells.

Authors:  J B Adams; R Vrahimis; N Phillips
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance.

Authors:  João Paulo G Camporez; François R Jornayvaz; Hui-Young Lee; Shoichi Kanda; Blas A Guigni; Mario Kahn; Varman T Samuel; Carla R O Carvalho; Kitt Falk Petersen; Michael J Jurczak; Gerald I Shulman
Journal:  Endocrinology       Date:  2013-01-30       Impact factor: 4.736

7.  Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.

Authors:  S Lundgren; S Kvinnsland; E Utaaker; O Bakke; P M Ueland
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.